An overview written by Clinton Veale (University of KwaZulu-Natal). The Pathogen Box is a 400 strong collection of drug like compounds, selected for their potential against several of the world’s most important neglected tropical diseases. This review is divided into eight sections in which each disease category of the Pathogen Box is discussed independently: Kinetoplastids (trypanosomiasis, leishmaniasis), cryptosporidiosis and toxoplasmosis, filariasis and wolbachia, schistosomiasis, dengue virus and trichuriasis, in addition to malaria and tuberculosis. The Pathogen Box represent a considerable means of stimulating open source drug discovery against diseases which threaten the world’s most vulnerable communities. Compounds in this library, have been selected from drug discovery campaigns which have utilized numerous techniques of identifying hit compounds including, phenotypic screening of both large and targeted libraries, as well as target based approaches.


[1]

  • C.G.L. Veale, "Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease", ChemMedChem, vol. 14, pp. 386-453, 2019. http://dx.doi.org/10.1002/cmdc.201800755

  • [1]

  • S. Scheer, S. Ackloo, T.S. Medina, M. Schapira, F. Li, J.A. Ward, A.M. Lewis, J.P. Northrop, P.L. Richardson, H.. Kaniskan, Y. Shen, J. Liu, D. Smil, D. McLeod, C.A. Zepeda-Velazquez, M. Luo, J. Jin, D. Barsyte-Lovejoy, K.V.M. Huber, D.D. De Carvalho, M. Vedadi, C. Zaph, P.J. Brown, and C.H. Arrowsmith, "A chemical biology toolbox to study protein methyltransferases and epigenetic signaling", Nature Communications, vol. 10, 2019. http://dx.doi.org/10.1038/s41467-018-07905-4
  • [1]

  • C. Denis, M.A.J. Dubois, A.S. Voisin-Chiret, R. Bureau, C. Choi, J.J. Mousseau, and J.A. Bull, "Synthesis of 3,3-Diarylazetidines by Calcium(II)-Catalyzed Friedel–Crafts Reaction of Azetidinols with Unexpected Cbz Enhanced Reactivity", Organic Letters, vol. 21, pp. 300-304, 2018. http://dx.doi.org/10.1021/acs.orglett.8b03745

  • [1]

  • I.O. Feskov, A.V. Chernykh, Y.O. Kuchkovska, C.G. Daniliuc, I.S. Kondratov, and O.O. Grygorenko, "3-((Hetera)cyclobutyl)azetidines, “Stretched” Analogues of Piperidine, Piperazine, and Morpholine: Advanced Building Blocks for Drug Discovery", The Journal of Organic Chemistry, vol. 84, pp. 1363-1371, 2018. http://dx.doi.org/10.1021/acs.joc.8b02822

  • [1]

  • V. Zoppi, S.J. Hughes, C. Maniaci, A. Testa, T. Gmaschitz, C. Wieshofer, M. Koegl, K.M. Riching, D.L. Daniels, A. Spallarossa, and A. Ciulli, "Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7", Journal of Medicinal Chemistry, vol. 62, pp. 699-726, 2018. http://dx.doi.org/10.1021/acs.jmedchem.8b01413
  • (MacMillan with Merck and Eli Lilly)

    [1]

  • R.T. Smith, X. Zhang, J.A. Rincón, J. Agejas, C. Mateos, M. Barberis, S. García-Cerrada, O. de Frutos, and D.W.C. MacMillan, "Metallaphotoredox-Catalyzed Cross-Electrophile Csp3–Csp3 Coupling of Aliphatic Bromides", Journal of the American Chemical Society, vol. 140, pp. 17433-17438, 2018. http://dx.doi.org/10.1021/jacs.8b12025